论文部分内容阅读
同种异体肾移植已为大多数尿毒症患者所接受，肾移植成功的关键之一，取决于移植肾排异反应的预防和治疗。以环孢素Ａ为主体的免疫抑制剂的联合应用使移植肾存活率大为提高。然而环孢素Ａ价格昂贵，长期服用给患者个人和家庭造成的经济负担有时难以承受。本院在１９８９—...
Allogeneic kidney transplantation has been accepted by most patients with uremia, and one of the keys to the success of renal transplantation depends on the prevention and treatment of transplant renal rejection. Cyclosporin A as the main immunosuppressive agents combined to make graft survival rate greatly improved. However, cyclosporin A is expensive and the economic burden of long-term use on individual patients and families is sometimes untenable. Our hospital in 1989 -...